Many MDs unaware their prescribing data are for sale
- Top-notch science op. Rollins, Gina // Modern Physician;Sep2002, Vol. 6 Issue 9, p22
Discusses the rewards and opportunities provided by the pharmaceutical industry to physician executives in the U.S. Main appeals of the industry to physicians; Perception on the industry; Qualities and skills that are important to physician executives in the pharmaceutical industry.
- Meet the EAB. Booth, Shannon // Applied Clinical Trials;Nov2003, Vol. 12 Issue 11, p40
No abstract available.
- Dialysis: High Costs and Hidden Perils of a Treatment Guaranteed to All: Dialysis Data, Once Confidential, Shines Light on Clinic Disparities. Fields, Robin // Pro Publica;12/19/2010, p16
An introduction is presented which discusses several reports published within the journal on topics including steps taken by drug companies to retain control of physicians presentation, payments made to doctors and failure of Pentagon health plan in covering brain-damage therapy troops.
- Drug Companies and Doctors: A Tight-Knit Community. // People's Medical Society Newsletter;Jun2001, Vol. 20 Issue 3, p2
Deals with the influence that drug manufacturers have over the prescribing and professional behavior of physicians according to an article in the January 19, 2001 issue of the `Journal of the American Medical Association.'
- Charging drug representatives for physician visits: Three leaders explain why and how. // Formulary;Nov2002, Vol. 37 Issue 11, p594
Presents physicians' views about the charging of drug representatives for physician visits. Benefits to physicians of drug representative visits; Reasons for the implementation of fee-for-visit policy; Number of pharmaceutical firms that have agreed to the policy. INSETS: Facts at a glance:...
- Physician Executives as Opinion Leaders in Biotechnology and Pharmaceuticals. Tan, Robert S. // Physician Executive;May/Jun2003, Vol. 29 Issue 3, p26
Discusses skills that a physician executive needs in order to become an advisor to biotechnology and pharmaceutical industries. Minimum benchmark of certification in clinical specialty; Advice customers about the product; Types of customers seeking opinions from physician executives.
- Do Industry Ties Influence Patient Care Guidelines? // Review of Optometry;3/15/2002, Vol. 139 Issue 3, p8
Investigates the relationships of physicians with pharmaceutical industry in relation to the writing of the patient care guidelines. Expansion of optometry practice; Influence of the relationship to the writing of the guidelines; Survey of the Journal of the American Medical Association...
- A MARKETER'S CURE FOR ATTENTION DEFICIT DISORDER. Vanderveer, Richard B.; Pines, Noah M. // Medical Marketing & Media;May2003, Vol. 38 Issue 5, p64
Offers suggestions on how pharmaceutical firms can market their products to physicians. Psychology of persuasion; Message engineering; Expansion and diversification of the pharmaceutical industry's promotional voice.
- Questions in the Commons. // British Medical Journal;6/28/1975, Vol. 2 Issue 5973, p759
Reports developments on medicine in Great Britain as of June 1975.. Impact of the reduction of promotion advertising on several publications of reference value to the medical profession; Recommendations of the Sainsbury Report on the Drug Industry; Provisional estimate for emigrating physicians.
- Doctors and Nurses: How Does the Medical Industry Influence Patient Care? // Pro Publica;5/ 1/2011, p25
The article invites the views and experiences of readers of this periodical, on the influence of pharmaceutical industry on physicians and medical associations, and the impact of the medical industry on patient care.